The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

UK BROKER RATINGS SUMMARY: Goldman Likes John Wood; Peel Cuts YouGov

Fri, 31st Jul 2020 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:

----------

FTSE 100

----------

CREDIT SUISSE CUTS SHELL PRICE TARGET TO 1,600 (1,700) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES SHELL B PRICE TARGET TO 1,450 (1,440) PENCE - 'HOLD'

----------

BERENBERG CUTS LLOYDS PRICE TARGET TO 30 (35) PENCE - 'HOLD'

----------

BARCLAYS RAISES SCHRODERS PRICE TARGET TO 2,920 (2,790) PENCE - 'EQUAL WEIGHT'

----------

BERENBERG RAISES SCHRODERS PRICE TARGET TO 3,200 (2,203) PENCE - 'HOLD'

----------

BARCLAYS RAISES 3I GROUP PRICE TARGET TO 1,200 (1,120) PENCE - 'OVERWEIGHT'

----------

JEFFERIES CUTS RSA INSURANCE PRICE TARGET TO 580 (600) PENCE - 'BUY'

----------

JPMORGAN RAISES INTERTEK PRICE TARGET TO 5,900 (5,200) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES AVEVA GROUP PRICE TARGET TO 4,600 (4,100) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES AVEVA GROUP PRICE TARGET TO 4,600 (4,100) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS CUTS BAE SYSTEMS PRICE TARGET TO 505 (514) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS BAE SYSTEMS PRICE TARGET TO 750 (765) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES MELROSE INDUSTRIES PRICE TARGET TO 105 PENCE - 'NEUTRAL'

----------

BARCLAYS RAISES RENTOKIL INITIAL PRICE TARGET TO 573 (446) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS COMPASS GROUP PRICE TARGET TO 1,000 (1,050) PENCE - 'UNDERWEIGHT'

----------

GOLDMAN SACHS CUTS COMPASS GROUP PRICE TARGET TO 1,310 (1,400) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS GLAXOSMITHKLINE PRICE TARGET TO 2,020 (2,060) PENCE - 'BUY'

----------

DZ BANK CUTS FAIR VALUE FOR GLAXOSMITHKLINE TO 1,850 (1,900) PENCE - 'BUY'

----------

DZ BANK RAISES FAIR VALUE FOR ASTRAZENECA TO 7,500 (7,300) PENCE - 'SELL'

----------

FTSE 250

----------

RBC CUTS LANCASHIRE HOLDINGS PRICE TARGET TO 950 (1,050) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES ULTRA ELECTRONICS PRICE TARGET TO 2,600 (2,550) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES ULTRA ELECTRONICS PRICE TARGET TO 2,600 (2,300) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES VESUVIUS PRICE TARGET TO 450 (420) PENCE - 'EQUAL-WEIGHT'

----------

RBC RAISES WEIR GROUP PRICE TARGET TO 1,680 (1,420) PENCE - 'OUTPERFORM'

----------

RBC CUTS MORGAN ADVANCED MATERIALS TARGET TO 265 (275) PENCE - 'SECTOR PERFORM'

----------

JPMORGAN RAISES BODYCOTE PRICE TARGET TO 670 (590) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES JOHN WOOD GROUP TO 'BUY' ('NEUTRAL')

----------

JEFFERIES RAISES DRAX GROUP PRICE TARGET TO 280 (170) PENCE - 'HOLD'

----------

BERENBERG CUTS GREENCORE PRICE TARGET TO 200 (210) PENCE - 'BUY'

----------

JPMORGAN RAISES B&M PRICE TARGET TO 430 (360) PENCE - 'NEUTRAL'

----------

OTHER MAIN MARKET AND AIM

----------

PEEL HUNT CUTS YOUGOV TO 'HOLD' (ADD) - PRICE TARGET 700 PENCE

----------

BERENBERG RAISES YOUGOV PRICE TARGET TO 920 (610) PENCE - 'BUY'

----------

RBC CUTS TED BAKER PRICE TARGET TO 70 (140) PENCE - 'UNDERPERFORM'

----------

LIBERUM CUTS FULLER SMITH & TURNER PRICE TARGET TO 700 (820) PENCE - 'HOLD'

----------

LIBERUM CUTS ROBERT WALTERS PRICE TARGET TO 535 (540) PENCE - 'BUY'

----------

BERENBERG RAISES CERES POWER PRICE TARGET TO 580 (470) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.